Cytomed Therapeutics LTD (GDTC) SEC Filings — 2024
14 SEC filings for Cytomed Therapeutics LTD (GDTC) in 2024.
Filings
- CytoMed Therapeutics Reports Rise in Collaborations — 6-K · Dec 5, 2024
- CytoMed Therapeutics Ltd. Files Form 6-K — 6-K · Nov 20, 2024
- CytoMed Therapeutics Announces Press Release — 6-K · Oct 7, 2024
- CytoMed Therapeutics Issues Press Release — 6-K · Oct 3, 2024
- CytoMed Therapeutics Files 6-K for June 30, 2024 Period — 6-K · Sep 30, 2024
- CytoMed Therapeutics Announces Board Re-organization — 6-K · Jun 20, 2024
- CytoMed Therapeutics Holds Annual Shareholders Meeting — 6-K · May 24, 2024
- Cytomed Therapeutics LTD SC 13G/A Filing — SC 13G/A · May 23, 2024
- CytoMed Therapeutics Files 6-K for Proxy Statement — 6-K · Apr 24, 2024
- CytoMed Therapeutics Ltd Files 20-F for Fiscal Year Ended December 31, 2023 — 20-F · Apr 22, 2024
- CytoMed Therapeutics Issues Press Release — 6-K · Mar 18, 2024
- CytoMed Therapeutics Issues March 4 Press Release — 6-K · Mar 4, 2024
- Cytomed Therapeutics LTD SC 13G Filing — SC 13G · Feb 14, 2024
- CytoMed Secures Malaysian Patent for Cancer-Targeting T-Cell Tech — 6-K · Jan 29, 2024